Publications

WA Weiss Pubmed

Ménard M, Yoda H, Nasholm N, Barata MJ, Wang L, Simonds EF, Lu ED, Wong-Michalak S, McHenry L, Farrel A, Kaufman R, Lopez V, Kennedy RJ, Fernandez GE, Shimada H, Grossmann LD, Asgharzadeh S, Maris JM, Gustafson WC, Weiss WA. Myeloid-targeting immunotherapies overcome inhibitory barriers in immune-evasive neuroblastoma. J Exp Med. 2025 Sep 1;222(9):e20231417. doi: 10.1084/jem.20231417. Epub 2025 Jul 14. PMID: 40658105

An Z, Fan QW, Wang L, Yoda H, Barata MJ, Jimenez-Morales D, Phillips JJ, Swaney DL, Stevenson E, Lee E, Krogan N, Weiss WA. EGFR and EGFRvIII coopt host defense pathways promoting progression in glioblastoma. Neuro Oncol. 2025 Feb 10;27(2):383-397. doi: 10.1093/neuonc/noae182. PMID: 39248287

Schmidt C, Cohen S, Gudenas BL, Husain S, Carlson A, Westelman S, Wang L, Phillips JJ, Northcott PA, Weiss WA, Schwer B. PRDM6 promotes medulloblastoma by repressing chromatin accessibility and altering gene expression. Sci Rep. 2024 Jul 12;14(1):16074. doi: 10.1038/s41598-024-66811-6. PMID: 38992221 

Huang M, Fang W, Farrel A, Li L, Chronopoulos A, Nasholm N, Cheng B, Zheng T, Yoda H, Barata MJ, Porras T, Miller ML, Zhen Q, Ghiglieri L, McHenry L, Wang L, Asgharzadeh S, Park J, Gustafson WC, Matthay KK, Maris JM, Weiss WA. ALK upregulates POSTN and WNT signaling to drive neuroblastoma. Cell Rep. 2024 Mar 26;43(3):113927. doi: 10.1016/j.celrep.2024.113927. Epub 2024 Mar 6. PMID: 38451815

Kuzuoglu-Ozturk D, Aksoy O, Schmidt C, Lea R, Larson JD, Phelps RRL, Nasholm N, Holt M, Contreras A, Huang M, Wong-Michalak S, Shao H, Wechsler-Reya R, Phillips JJ, Gestwicki JE, Ruggero D, Weiss WA. N-myc-Mediated Translation Control Is a Therapeutic Vulnerability in Medulloblastoma. Cancer Res. 2023 Jan 4;83(1):130-140. doi: 10.1158/0008-5472.CAN-22-0945. PMID: 36264168

Beytagh MC, Weiss WA. EGFR ligands dictate tumour suppression. Nat Cell Biol. 2022 Aug;24(8):1189-1191. doi: 10.1038/s41556-022-00967-z. PMID: 35915160

Sandoval K, Weiss WA. Nuclear tetraspanin 8 promotes breast cancer progression. Cell Res. 2022 Jun;32(6):511-512. doi: 10.1038/s41422-022-00657-3. No abstract available. PubMed [citation] PMID: 35418219

Yoda H, Weiss WA. CD55, a potential immunotherapeutic target for MYCN-amplified neuroblastoma. Neuro Oncol. 2022 Jun 1;24(6):886-887. doi: 10.1093/neuonc/noac020. No abstract available. PubMed [citation] PMID: 35090034

Lindquist RA, Weiss WA. All eyes on a phosphatase in glioma stem cells. J Exp Med. 2021 Nov 1;218(11). pii: e20211605. doi: 10.1084/jem.20211605. Epub 2021 Oct 12. PubMed [citation] PMID: 34637499, PMCID: PMC8517169

Qadeer ZA, Weiss WA. A SHHecret target of relapsed medulloblastoma: Astrocytes. J Exp Med. 2021 Sep 6;218(9). pii: e20211141. doi: 10.1084/jem.20211141. Epub 2021  Aug 16. PubMed [citation] PMID: 34398189, PMCID: PMC8424466

Simonds EF, Lu ED, Badillo O, Karimi S, Liu EV, Tamaki W, Rancan C, Downey KM, Stultz J, Sinha M, McHenry LK, Nasholm NM, Chuntova P, Sundström A, Genoud V, Shahani SA, Wang LD, Brown CE, Walker PR, Swartling FJ, Fong L, Okada H, Weiss WA, Hellström M. Deep immune profiling reveals targetable mechanisms of immune evasion in immune checkpoint inhibitor-refractory glioblastoma. J Immunother Cancer. 2021 Jun;9(6). pii: e002181. doi: 10.1136/jitc-2020-002181. PubMed [citation] PMID: 34083417, PMCID: PMC8183210

Luo X, Weiss WA. Utility of Human-Derived Models for Glioblastoma. Cancer Discov. 2020 Jul;10(7):907-909. doi: 10.1158/2159-8290.CD-20-0493. PubMed [citation] PMID: 32611734, PMCID: PMC8283797

Dirks PB, Gilbert MR, Holland EC, Maher EA, Weiss WA. Translating Basic Science Discoveries into Improved Outcomes for Glioblastoma. Clin Cancer Res. 2020 Jun 1;26(11):2457-2460. doi: 10.1158/1078-0432.CCR-19-3924. Epub 2020 Feb 14. PubMed [citation] PMID: 32060102, PMCID: PMC7269826

Wong RA, Luo X, Lu M, An Z, Haas-Kogan DA, Phillips JJ, Shokat KM, Weiss WA, Fan QW. Cooperative Blockade of PKCα and JAK2 Drives Apoptosis in Glioblastoma. Cancer Res. 2020 Feb 15;80(4):709-718. doi: 10.1158/0008-5472.CAN-18-2808. Epub 2019 Dec 5. PubMed [citation] PMID: 31806641, PMCID: PMC7024655

Russ JB, Weiss WA. Conversations on mutism: risk stratification for cerebellar mutism based on medulloblastoma subtype. Neuro Oncol. 2020 Feb 20;22(2):175-176. doi: 10.1093/neuonc/noz228. No abstract available. PubMed [citation] PMID: 31792531, PMCID: PMC7032622

An Z, Knobbe-Thomsen CB, Wan X, Fan QW, Reifenberger G, Weiss WA. Correction: EGFR Cooperates with EGFRvIII to Recruit Macrophages in Glioblastoma. Cancer Res. 2019 Nov 1;79(21):5681. doi: 10.1158/0008-5472.CAN-19-2800. No abstract available. PubMed [citation] PMID: 31676678

Fan Q, An Z, Wong RA, Luo X, Lu ED, Baldwin A, Mayekar MK, Haderk F, Shokat KM, Bivona TG, Weiss WA. Betacellulin drives therapy resistance in glioblastoma. Neuro Oncol. 2020 Apr 15;22(4):457-469. doi: 10.1093/neuonc/noz206. PubMed [citation] PMID: 31678994, PMCID: PMC7158663